|
1
|
Tang L, Chen Q, Meng Z, Sun L, Zhu L, Liu
J, Hu J, Ni Z and Wang X: suppression of sirtuin-1 increases IL-6
expression by activation of the Akt pathway during allergic asthma.
Cell Physiol Biochem. 43:1950–1960. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ding F, Fu Z and Liu B: Lipopolysaccharide
exposure alleviates asthma in mice by regulating Th1/Th2 and
Treg/Th17 balance. Med Sci Monit. 24:3220–3229. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Islam S, Abiko Y, Uehara O and Chiba I:
Sirtuin 1 and oral cancer. Oncol Lett. 17:729–738. 2019.PubMed/NCBI
|
|
4
|
Kida Y and Goligorsky MS: Sirtuins, cell
senescence, and vascular aging. Can J Cardiol. 32:634–641. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin Z and Fang D: The roles of SIRT1 in
cancer. Genes Cancer. 4:97–104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rahman S and Islam R: Mammalian Sirt1:
Insights on its biological functions. Cell Commun Signal. 9:112011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Potteti HR, Rajasekaran S, Rajamohan SB,
Tamatam CR, Reddy NM and Reddy SP: Sirtuin 1 promotes
hyperoxia-induced lung epithelial cell death independent of
NF-E2-related factor 2 activation. Am J Respir Cell Mol Biol.
54:697–706. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim SR, Lee KS, Park SJ, Min KH, Choe YH,
Moon H, Yoo WH, Chae HJ, Han MK and Lee YC: Involvement of sirtuin
1 in airway inflammation and hyperresponsiveness of allergic airway
disease. J Allergy Clin Immunol. 125:449–460.e4. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Li D, Ma G, Li W, Wu J, Lai T,
Huang D, Zhao X, Lv Q, Chen M and Wu B: Increases in peripheral
SIRT1: A new biological characteristic of asthma. Respirology.
20:1066–1072. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Y, Yang F, Zou S and Qu L: Rapamycin:
A bacteria-derived immunosuppressant that has anti-atherosclerotic
effects and its clinical application. Front Pharmacol. 9:15202019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saxton RA and Sabatini DM: mTOR signaling
in growth, metabolism, and disease. Cell. 168:960–976. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin J, Huo X and Liu X: ‘mTOR signaling
pathway’: A potential target of curcumin in the treatment of spinal
cord injury. Biomed Res Int. 2017:16348012017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salido-Vallejo R, Garnacho-Saucedo G and
Vélez A: Elucidation of the mTOR pathway and therapeutic
applications in dermatology. Actas Dermosifiliogr. 107:379–390.
2016.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Perl A: Activation of mTOR (mechanistic
target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol.
12:169–182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Liu J, Zhou JS, Huang HQ, Li ZY,
Xu XC, Lai TW, Hu Y, Zhou HB, Chen HP, et al: MTOR suppresses
cigarette smoke-induced epithelial cell death and airway
inflammation in chronic obstructive pulmonary disease. J Immunol.
200:2571–2580. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zou H, Wang LX, Wang M, Cheng C, Li S,
Shen Q, Fang L and Liu R: MTOR-mediated autophagy is involved in
the protective effect of ketamine on allergic airway inflammation.
J Immunol Res. 2019:58797142019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng Z, Wang X, Dai L, Jia L, Jing X, Liu
Y, Wang H, Li P, An L and Liu M: Suppression of microRNA-384
enhances autophagy of airway smooth muscle cells in asthmatic
mouse. Oncotarget. 8:67933–67941. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Farooq MB and Walsh GM: Autophagy and
asthma. Clin Exp Allergy. 46:7–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Urbanska M, Gozdz A, Swiech LJ and
Jaworski J: Mammalian target of rapamycin complex 1 (mTORC1) and 2
(mTORC2) control the dendritic arbor morphology of hippocampal
neurons. J Biol Chem. 287:30240–30256. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma L, Dong W, Wang R, Li Y, Xu B, Zhang J,
Zhao Z and Wang Y: Effect of caloric restriction on the SIRT1/mTOR
signaling pathways in senile mice. Brain Res Bull. 116:67–72. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo W, Qian L, Zhang J, Zhang W, Morrison
A, Hayes P, Wilson S, Chen T and Zhao J: Sirt1 overexpression in
neurons promotes neurite outgrowth and cell survival through
inhibition of the mTOR signaling. J Neurosci Res. 89:1723–1736.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang J, Tian R, Yang Y, Jiang R, Dai J,
Tang L and Zhang L: The SIRT1 inhibitor EX-527 suppresses mTOR
activation and alleviates acute lung injury in mice with
endotoxiemia. Innate Immun. 23:678–686. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou X, Fan LX, Sweeney WE Jr, Denu JM,
Avner ED and Li X: Sirtuin 1 inhibition delays cyst formation in
autosomal-dominant polycystic kidney disease. J Clin Invest.
123:3084–3098. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang R, Tang D, Lotze MT and Zeh Iii HJ:
Autophagy is required for IL-2-mediated fibroblast growth. Exp Cell
Res. 319:556–565. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mushaben EM, Kramer EL, Brandt EB, Khurana
Hershey GK and Le Cras TD: Rapamycin attenuates airway
hyperreactivity, goblet cells, and IgE in experimental allergic
asthma. J Immunol. 187:5756–5763. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shao YY, Zhou YM, Hu M, Li JZ, Chen CJ,
Wang YJ, Shi XY, Wang WJ and Zhang TT: The anti-allergic rhinitis
effect of traditional Chinese medicine of shenqi by regulating mast
cell degranulation and Th1/Th2 cytokine balance. Molecules.
22:E5042017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee M, Kim S, Kwon OK, Oh SR, Lee HK and
Ahn K: Anti-inflammatory and anti-asthmatic effects of resveratrol,
a polyphenolic stilbene, in a mouse model of allergic asthma. Int
Immunopharmacol. 9:418–424. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang WR, Li TT, Jing T, Li YX, Yang XF, He
YH, Zhang W, Lin R and Zhang JY: SIRT1 regulates the inflammatory
response of vascular adventitial fibroblasts through autophagy and
related signaling pathway. Cell Physiol Biochem. 41:569–582. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo G, Jian Z, Zhu Y, Zhu Y, Chen B, Ma R,
Tang F and Xiao Y: Sirt1 promotes autophagy and inhibits apoptosis
to protect cardiomyocytes from hypoxic stress. Int J Mol Med.
43:2033–2043. 2019.PubMed/NCBI
|
|
30
|
Tan FH, Bai Y, Saintigny P and Darido C:
mTOR signalling in head and neck cancer: Heads up. Cells.
8:E3332019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rabanal-Ruiz Y, Otten EG and Korolchuk VI:
mTORC1 as the main gateway to autophagy. Essays Biochem.
61:565–584. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu X, Chu H, Jiang S, Liu Q, Liu L, Xue
Y, Zheng S, Wan W, Qiu J, Wang J and Zou H: Sirt1 ameliorates
systemic sclerosis by targeting the mTOR pathway. J Dermatol Sci.
87:149–158. 2017. View Article : Google Scholar : PubMed/NCBI
|
